|
BMT Quality Reporting: Clinical Chart Audit |
10/07/2025 - 8:45am to 9:30am MDT |
|
Steroids and the Blood Brain Barrier: Rumor and Reality |
09/30/2025 - 8:45am to 9:30am MDT |
|
Beat the Clock: How Biological Timing Impacts Transplantation and Cell Therapy |
09/23/2025 - 8:45am to 9:30am MDT |
|
CAR T cell therapy and T cell malignancies |
09/16/2025 - 8:45am to 9:30am MDT |
|
Pulmonary Function after Hematopoietic Cell Transplant for Sickle Cell Disease + Fellow Research Presentation |
09/02/2025 - 8:45am to 9:30am MDT |
|
Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group |
08/26/2025 - 8:45am to 9:30am MDT |
|
CAR T cells for AML: Where are we now and where are we going? |
08/19/2025 - 8:45am to 9:30am MDT |
|
Atypical GVHD |
08/12/2025 - 8:45am to 9:30am MDT |
|
BMT Quality Reporting: Morbidity and Mortality |
08/05/2025 - 8:45am to 9:30am MDT |
|
Remestemcel-L-rknd (Ryoncil®) for Steroid-Refractory aGVHD: Novel Therapy at a High Cost |
07/29/2025 - 8:45am to 9:30am MDT |